Loading
Latest filing published 14 Oct 2026 for ABIVAX, €274k. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Marc De Garidel on record concern Abivax. We count 5 filings; the first trade dates from 26 June 2026 and the latest from 12 October 2026.
Market trades split into 4 purchases and 1 sale (€274k). The amount is not disclosed for 4 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 14 October 2026 came the latest disclosure, an open-market sale for €274k in Abivax. The last purchase on record was published on 13 October 2026, which is 4 days ago. Typically, a trade is published a median of 2 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations